Results 41 to 50 of about 3,735,339 (297)

A case of disseminated intravascular coagulation secondary to Acinetobacter lwoffii and Acinetobacter baumannii bacteremia

open access: yesIDCases, 2015
Bacteremia is currently one of the infections with the highest mortality in hospitals [1]. Acinetobacter lwoffii and Acinetobacter baumannii are gram-negative bacteria and both represent opportunistic pathogens.
Candice Baldeo   +3 more
doaj   +1 more source

Genomic Diversity of Bacteriophages Infecting the Genus Acinetobacter [PDF]

open access: yesViruses, 2022
The number of sequenced Acinetobacter phage genomes in the International Nucleotide Sequence Database Collaboration has increased significantly in recent years, from 37 in 2017 to a total of 139 as of January 2021 with genome sizes ranging from 31 to 378 kb.
Hugo Oliveira   +5 more
openaire   +6 more sources

Experimental Models of Acinetobacter Infection [PDF]

open access: yes, 2008
The use of animals as models for microbiological infections is a fundamental part of infectious disease research. The intent for the use of animals as models of disease is to establish an infection that mimics that seen in humans (Druilhe et al., 2002). The goal is to seek how the infection develops, and by what the infection can be thwarted.
Joly-Guillou, Marie-Laure, Wolff, Michel
openaire   +2 more sources

Acinetobacter Metabolism in Infection and Antimicrobial Resistance

open access: yesInfection and Immunity, 2023
Acinetobacter infections have high rates of mortality due to an increasing incidence of infections by multidrug-resistant (MDR) and extensively-drug-resistant (XDR) strains. Therefore, new therapeutic strategies for the treatment of Acinetobacter infections are urgently needed. Acinetobacter
Xiaomei Ren, Lauren D. Palmer
openaire   +2 more sources

In vitro activity of curcumin in combination with epigallocatechin gallate (EGCG) versus multidrug-resistant Acinetobacter baumannii [PDF]

open access: yes, 2014
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Wareham, DW   +3 more
core   +1 more source

Comparative evaluation of in-vitro synergy testing methods (Etest, Broth Microdilution and Time kill assay) in carbapenem resistant Acinetobacter species

open access: yesJournal of Microbiology and Infectious Diseases, 2019
Objective: There is an increasing incidence of Acinetobacter species causing serious hospital acquired infections such as blood stream infections (BSI), catheter associated urinary tract infections (CAUTI) and lower respiratory tract infections(LRTI ...
Ranu Soni   +4 more
doaj   +1 more source

Colistin-Resistant Acinetobacter baumannii as a cause of Neonatal Ventriculitis

open access: yesSouthern African Journal of Infectious Diseases, 2018
Acinetobacter baumannii causes invasive paediatric infections, including bacteraemia and meningitis, but neonatal meningitis and ventriculitis is uncommon.
Prasha Mahabeer   +5 more
doaj   +1 more source

Recent Progress in Phage Therapy to Modulate Multidrug-Resistant Acinetobacter baumannii, including in Human and Poultry

open access: yesAntibiotics, 2022
Acinetobacter baumannii is a multidrug-resistant and invasive pathogen associated with the etiopathology of both an increasing number of nosocomial infections and is of relevance to poultry production systems.
Yan Zhang   +14 more
doaj   +1 more source

Discovery and Biosynthesis of the Novel Glycotetrapeptide Antibiotic Biffamycin A

open access: yesAngewandte Chemie, EarlyView.
Genetic de‐regulation of a silent biosynthetic pathway allowed isolation and characterisation of a novel glycopeptide antibiotic named biffamycin A, which harbours unprecedented 5‐chloro‐4‐methoxy tryptophan and 3R‐hydroxy(α‐D‐mannoysl)‐D‐lysine moieties and is bioactive against MRSA and VRSA.
Michael W. Brigham   +11 more
wiley   +2 more sources

The transmission of nosocomial pathogens in an intensive care unit: a space–time clustering and structural equation modelling approach

open access: yes, 2010
We investigated the incidence of cases of nosocomial pathogens and risk factors in an intensive treatment unit ward to determine if the number of cases is dependent on location of patients and the colonization/infection history of the ward.
Sheridan, E. A.   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy